Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daivobet gel versus Daivonex/Dovonex scalp solution in scalp psoriasis
2005-002864-27Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Sep 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in psoriasis comparing DAIVOBET/DOVOBET gel once daily with DAIVONEX/DOVONEX scalp solution twice daily (2 arms). Primary endpoint: Controlled disease at end of treatment. Started Sep 2005; status: completed.
02
Drugs
calcipotriol + betamethasonecalcipotriol
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2005-002864-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002864-27.